- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03737877
The Feasibility of a Dietary Intervention in Children With ADHD
The Feasibility of a Microbiome Dietary Intervention in Children With ADHD
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
London, United Kingdom, TW14SX
- St Mary's University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Parent-reported diagnosis of ADHD.
- Children aged between 8 years - 13 years 11 months at onset of study.
- Children not taking ADHD medication (such as methylphenidate) at the time of the study.
- Parental permission to attend three group sessions and for themselves and their child to complete the requisite assessments.
- Both males and females are eligible to take part.
- Children with a co-occurring diagnosis will be accepted onto the trial.
- Children with food allergies/sensitivities/coeliac disease will be accepted onto the trial.
Exclusion Criteria:
- Children undergoing a current course of behavioural therapy.
- Children currently on ADHD medication (such as methylphenidate).
- Children who have taken antibiotics in the past 3 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Diet modification
|
The parents will have four group sessions with a nutritional therapist, where in depth advice and information about the diet will be provided. Ongoing support will also be provided throughout the study by use of a closed Facebook or WhatsApp group (whichever the parents choose as most appropriate). The diet is based on five main principles:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Completion of study
Time Frame: final week
|
What proportion of participants completed the study?
|
final week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence to diet
Time Frame: week 6 of diet
|
Percentage adherence to diet over the 4-week period based on parental report (range 0-100 % - high score reflecting greater degree of adherence).
|
week 6 of diet
|
|
Side-effects
Time Frame: duration of the 6 week diet
|
Parent-reported side effects during course of study.
(Qualitative) (More/more side-effects reflect poorer outcome).
|
duration of the 6 week diet
|
|
The Conners Clinical Index (Conners CI) - Parent-report
Time Frame: Baseline and week 6 of diet
|
Parental report of clinical symptoms (percentile score - higher score reflects more/more severe symptoms)
|
Baseline and week 6 of diet
|
|
The Conners Clinical Index (Conners CI) - Teacher-report
Time Frame: Baseline and week 6 of diet
|
Teacher report of clinical symptoms (percentile score - higher score reflects more/more severe symptoms)
|
Baseline and week 6 of diet
|
|
The Conners Clinical Index (Conners CI) - Self-report
Time Frame: Baseline and week 6 of diet
|
Child self-report of clinical symptoms (percentile score - higher score reflects more/more severe symptoms)
|
Baseline and week 6 of diet
|
|
Delayed Match to Sample test (Cambridge Neuropsychological Test Automated Battery - CANTAB) Latency (response time) Accuracy (correct patterns selected).
Time Frame: Baseline and week 6 of diet
|
Computerised test of visual working memory
|
Baseline and week 6 of diet
|
|
The Consensus Sleep Diary
Time Frame: Baseline and week 6 of diet
|
Record of sleep - used qualitatively to detect and remove artefacts from the data.
|
Baseline and week 6 of diet
|
|
Children's Sleep Habits Questionnaire
Time Frame: Baseline and week 6 of diet
|
Parental report of child's sleep A Total Sleep Disturbances score is calculated as the sum of all CSHQ scored questions, and can range from 33 to 99.
A higher score indicates more problematic sleep.
|
Baseline and week 6 of diet
|
|
Sleep self-report questionnaire
Time Frame: Baseline and week 6 of diet
|
Week long retrospective sleep survey (Scores range from 13-39 with a higher score indicating more/more severe sleep difficulties).
|
Baseline and week 6 of diet
|
|
Actigraphy recordings
Time Frame: Baseline and week 6 of diet
|
Objective measure of sleep quality and daytime activity
|
Baseline and week 6 of diet
|
|
The Gastrointestinal Symptom Rating
Time Frame: Baseline and week 6 of diet
|
Questionnaire to evaluate common gastrointestinal symptoms Total scores range from 15-105 (with higher scores reflecting more/more severe gastrointestinal symptoms). Subscales:
|
Baseline and week 6 of diet
|
|
Stool sample analysis for commensal bacteria and microbial diversity using 16S rRNA sequencing
Time Frame: Baseline and week 6 of diet
|
Analysis of bacterial strains and diversity within stool sample
|
Baseline and week 6 of diet
|
|
Treatment Acceptability Scale
Time Frame: Baseline and week 6 of diet
|
Questionnaire to assess the acceptability of the diet to parents of the children taking part in the study Score range 6-42 (High score reflects more positive attitude to treatment)
|
Baseline and week 6 of diet
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- SMEC_2017-18_132
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diet Modification
-
University of Rhode IslandCompletedDiet Modification | Diet HabitUnited States
-
University of ReadingCompletedDiet Modification | Diet, Healthy | Diet HabitUnited Kingdom
-
University of Rhode IslandBrown University; University of ConnecticutCompletedDiet ModificationUnited States
-
Purdue UniversityCompletedDiet ModificationUnited States
-
Quadram Institute BioscienceNorfolk and Norwich University Hospitals NHS Foundation TrustCompleted
-
Loma Linda UniversityArdmore Institute of HealthCompleted
-
University Hospital Southampton NHS Foundation...Medical Research Council; University of SouthamptonCompleted
-
Sibylle Kranz, PhD, RDNRecruitingDiet ModificationUnited States
-
University Hospital Southampton NHS Foundation...Medical Research Council; University of Southampton; National Institute for Health... and other collaboratorsActive, not recruitingDiet ModificationUnited Kingdom
Clinical Trials on Diet modification
-
University of WashingtonNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
University of WashingtonNational Heart, Lung, and Blood Institute (NHLBI)RecruitingChild Obesity | Eating | GliosisUnited States
-
Insel Gruppe AG, University Hospital BernTerminated
-
Georgetown UniversityUnknownSleep Disordered Breathing | Chronic TonsillitisUnited States
-
University Hospital TuebingenRecruiting
-
University of WashingtonNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruiting
-
Wake Forest University Health SciencesSidney Kimmel Comprehensive Cancer Center at Johns HopkinsCompletedGlioblastoma MultiformeUnited States
-
Springfield CollegeWestern New England Renal & Transplant AssociatesCompletedPatients With Stage 2-4 Chronic Kidney DiseaseUnited States
-
Sinai UniversityCompletedType 2 Diabetes Mellitus | Chronic Kidney Disease | Stage 4 Chronic Kidney Disease | Stage 3 Chronic Kidney Disease | Inflammation, Chronic Low-GradeEgypt
-
University of PennsylvaniaUniversity of Alabama at BirminghamCompletedFecal Incontinence | Incontinence | Bowel Incontinence | Accidental Bowel LeakageUnited States